Technology | August 12, 2009

Invivo Releases an Interventional MR Biopsy Solution for Prostate

August 12, 2009 - Invivo Corp. launches DynaTRIM, a first-of-its-kind fully MR compatible interventional device for Trans-Rectal Interventional MR (TRIM) biopsy of the prostate gland.
This complete clinical MR solution for prostate combines new DynaCAD for Prostate, an advanced clinical visualization system, and new DynaTRIM, a device for the first MR-guided intervention application. The combined solution offers a truly new imaging and intervention option for many patients with elevated and/or rising PSA levels.

Over the past five years, at the following clinical sites - Fox Chase Cancer Center, Philadelphia, Penn., Radboud University of Nijmegen, The Netherlands, University of Chicago, Ill., and Desert Medical Imaging, Indian Wells, Calif. - clinicians have assisted Invivo in the evaluation of this software with its comprehensive set of advanced prostate image visualization tools for performing real-time image analysis and interventional procedure planning.

“DynaCAD for Prostate provides increased operational efficiency enabling the radiologist to rapidly interpret the 3,000 images that constitute a dynamic contrast enhanced prostate MRI,” said John Feller, Chief Medical Officer at Desert Medical Imaging.

The Urologist faces the dilemma of patients with elevated and/or rising PSA levels and negative TRUS-guided biopsy results. The Invivo complete clinical MR prostate solution is designed to offer an alternative to keeping patients in an uncertain state. DynaTRIM reportedly enables the physician to conduct targeted MRI-guided interventions of the prostate gland reducing the number of cores acquired during biopsy. “Especially for patients that have had several sessions of biopsies with negative results; they only need a maximum of 4 MR-guided biopsies with a detection rate of 59 percent,” according to Dr. Inge von Oort, Onocological Urologist, University of Medical Center Nijmegen, the Netherlands.

For more information:

Related Content

News | Biopsy Systems | March 29, 2019
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy...
FDA Clears Ion Endoluminal Lung Biopsy System
Technology | Interventional Radiology | February 20, 2019
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...